The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Vaccine delivery using nanoparticles
Open accessAbstract
Vaccination has had a major impact on the control of infectious diseases. However, there are still many infectious diseases for which the development of an effective vaccine has been elusive. In many cases the failure to devise vaccines is a consequence of the inability of vaccine candidates to evoke appropriate immune responses. This is especially true where cellular immunity is required for protective immunity and this problem is compounded by the move toward devising sub-unit vaccines. Over the past decade nanoscale size (<1000 nm) materials such as virus-like particles, liposomes, ISCOMs, polymeric, and non-degradable nanospheres have received attention as potential delivery vehicles for vaccine antigens which can both stabilize vaccine antigens and act as adjuvants. Importantly, some of these nanoparticles (NPs) are able to enter antigen-presenting cells by different pathways, thereby modulating the immune response to the antigen. This may be critical for the induction of protective Th1-type immune responses to intracellular pathogens. Their properties also make them suitable for the delivery of antigens at mucosal surfaces and for intradermal administration. In this review we compare the utilities of different NP systems for the delivery of sub-unit vaccines and evaluate the potential of these delivery systems for the development of new vaccines against a range of pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A study of the nucleation and growth processes in the synthesis of colloidal gold
Turkevich, J., Stevenson, P. C., & Hillier, J. (1951) · Discussions of the Faraday Society · doi:10.1039/df9511100055 · Cited by 7,792
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity
Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J., & Wyatt, M. D. (2005) · Small · doi:10.1002/smll.200400093 · Cited by 2,406
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Role of target geometry in phagocytosis
Champion, J. A., & Mitragotri, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600997103 · Cited by 2,074
Size‐Dependent Cytotoxicity of Gold Nanoparticles
Pan, Y., Neuss, S., Leifert, A., Fischler, M., Wen, F., Simon, U., Schmid, G., Brandau, W., & Jahnen‐Dechent, W. (2007) · Small · doi:10.1002/smll.200700378 · Cited by 1,878
Shukla, R., Bansal, V., Chaudhary, M., Basu, A., Bhonde, R. R., & Sastry, M. (2005) · Langmuir · doi:10.1021/la0513712 · Cited by 1,687
Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17398-4 · Cited by 1,643
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
Iversen, T.-G., Skotland, T., & Sandvig, K. (2011) · Nano Today · doi:10.1016/j.nantod.2011.02.003 · Cited by 1,239
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency
Mao, H.-Q., Roy, K., Troung-Le, V. L., Janes, K. A., Lin, K. Y., Wang, Y., August, J. T., & Leong, K. W. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00361-8 · Cited by 1,228
Letchford, K., & Burt, H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.11.009 · Cited by 1,143
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.
Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., & Robinson, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11478 · Cited by 1,115
Sahoo, S. K., Panyam, J., Prabha, S., & Labhasetwar, V. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00127-x · Cited by 990
Haran, G., Cohen, R., Bar, L. K., & Barenholz, Y. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90105-9 · Cited by 934
Xia, T., Kovochich, M., Liong, M., Meng, H., Kabehie, S., George, S., Zink, J. I., & Nel, A. E. (2009) · ACS Nano · doi:10.1021/nn900918w · Cited by 933
Liposomal Drug Delivery Systems: An Update Review
Samad, A., Sultana, Y., & Aqil, M. (2007) · Current Drug Delivery · doi:10.2174/156720107782151269 · Cited by 906
Current advances in research and clinical applications of PLGA-based nanotechnology
Lü, J.-M., Wang, X., Marin-Muller, C., Wang, H., Lin, P. H., Yao, Q., & Chen, C. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.15 · Cited by 903
Foged, C., Brodin, B., Frokjaer, S., & Sundblad, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.035 · Cited by 871
Virus-like particles in vaccine development
Roldão, A., Mellado, M. C. M., Castilho, L. R., Carrondo, M. J., & Alves, P. M. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.115 · Cited by 845
Calvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012128907225 · Cited by 817
Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles
Xu, Y., & Du, Y. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00548-3 · Cited by 816
Preparation of microspheres by the solvent evaporation technique
O'Donnell, P. B., & McGinity, J. W. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00049-5 · Cited by 806
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
Merdan, T., Kopec̆ek, J., & Kissel, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00046-7 · Cited by 785
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses
Morein, B., Sundquist, B., Höglund, S., Dalsgaard, K., & Osterhaus, A. (1984) · Nature · doi:10.1038/308457a0 · Cited by 708
Hillyer, J. F., & Albrecht, R. M. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1143 · Cited by 706
The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and Pitfalls
Vercauteren, D., Vandenbroucke, R. E., Jones, A. T., Rejman, J., Demeester, J., De Smedt, S. C., Sanders, N. N., & Braeckmans, K. (2010) · Molecular Therapy · doi:10.1038/mt.2009.281 · Cited by 689
Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP3
Li, H., Willingham, S. B., Ting, J. P.-Y., & Re, F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.17 · Cited by 675
Chitosan Reduced Gold Nanoparticles as Novel Carriers for Transmucosal Delivery of Insulin
Bhumkar, D. R., Joshi, H. M., Sastry, M., & Pokharkar, V. B. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9257-9 · Cited by 624
The perfect mix: recent progress in adjuvant research
Guy, B. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1681 · Cited by 620
Shape Induced Inhibition of Phagocytosis of Polymer Particles
Champion, J. A., & Mitragotri, S. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9626-z · Cited by 617
Pharmacological Inhibition of Endocytic Pathways: Is It Specific Enough to Be Useful?
Ivanov, A. I. (2008) · Methods in Molecular Biology · doi:10.1007/978-1-59745-178-9_2 · Cited by 601
Breitburd, F., Kirnbauer, R., Hubbert, N. L., Nonnenmacher, B., Trin-Dinh-Desmarquet, C., Orth, G., Schiller, J. T., & Lowy, D. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3959-3963.1995 · Cited by 589
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
Fernández-Urrusuno, R., Calvo, P., Remuñán-López, C., Vila-Jato, J. L., & José Alonso, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1018908705446 · Cited by 587
Virus-like particles: Passport to immune recognition
Grgacic, E. V. L., & Anderson, D. A. (2006) · Methods · doi:10.1016/j.ymeth.2006.07.018 · Cited by 582
Dhar, S., Daniel, W. L., Giljohann, D. A., Mirkin, C. A., & Lippard, S. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9071282 · Cited by 510
GIANNINI, S., HANON, E., MORIS, P., VANMECHELEN, M., MOREL, S., DESSY, F., FOURNEAU, M., COLAU, B., SUZICH, J., & LOSONKSY, G. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.005 · Cited by 496
Construction and Characterization of Virus-Like Particles: A Review
Zeltins, A. (2013) · Molecular Biotechnology · doi:10.1007/s12033-012-9598-4 · Cited by 478
Villa, L. L., Ault, K. A., Giuliano, A. R., Costa, R. L. R., Petta, C. A., Andrade, R. P., Brown, D. R., Ferenczy, A., Harper, D. M., Koutsky, L. A., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.068 · Cited by 469
Goren, D., Horowitz, A. T., Tzemach, D., Tarshish, M., Zalipsky, S., & Gabizón, A. (2000) · PubMed · Cited by 468
Polymer particle shape independently influences binding and internalization by macrophages
Sharma, G., Valenta, D. T., Altman, Y., Harvey, S., Xie, H., Mitragotri, S., & Smith, J. W. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.116 · Cited by 466
Olsson, S.-E., Villa, L. L., Costa, R. L. R., Petta, C. A., Andrade, R. P., Malm, C., Iversen, O.-E., Høye, J., Steinwall, M., Riis-Johannessen, G., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.049 · Cited by 454
Vaccine design : the subunit and adjuvant approach
Powell, M. F., Newman, M. J., & Burdman, J. R. (1995) · Plenum Press eBooks · Cited by 451
Poly(l-histidine)–PEG block copolymer micelles and pH-induced destabilization
Lee, E. S., Shin, H. J., Na, K., & Bae, Y. H. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00205-0 · Cited by 451
dos Santos, T., Varela, J., Lynch, I., Salvati, A., & Dawson, K. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024438 · Cited by 445
PLA/PLGA nanoparticles for sustained release of docetaxel
Musumeci, T., Ventura, C. A., Giannone, I., Ruozi, B., Montenegro, L., Pignatello, R., & Puglisi, G. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.023 · Cited by 435
Shen, H., Ackerman, A. L., Cody, V., Giodini, A., Hinson, E. R., Cresswell, P., Edelson, R. L., Saltzman, W. M., & Hanlon, D. J. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02268.x · Cited by 420
Preparation of chitosan self-aggregates as a gene delivery system
Lee, K. Y., Kwon, I. C., Kim, Y.-H., Jo, W. H., & Jeong, S. Y. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00173-9 · Cited by 396
McKee, A. S., Munks, M. W., MacLeod, M. K. L., Fleenor, C. J., Van Rooijen, N., Kappler, J. W., & Marrack, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900164 · Cited by 392
Holowka, E. P., Sun, V. Z., Kamei, D. T., & Deming, T. J. (2007) · Nature Materials · doi:10.1038/nmat1794 · Cited by 370
Mechanisms of stimulation of the immune response by aluminum adjuvants
HogenEsch, H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00169-x · Cited by 354
Cellular Uptake and Toxicity of Au55 Clusters
Tsoli, M., Kuhn, H., Brandau, W., Esche, H., & Schmid, G. (2005) · Small · doi:10.1002/smll.200500104 · Cited by 334
Aluminum Hydroxide Adjuvants Activate Caspase-1 and Induce IL-1β and IL-18 Release
Li, H., Nookala, S., & Re, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5271 · Cited by 332
Immunity in response to particulate antigen-delivery systems
STORNI, T., KUNDIG, T., SENTI, G., & JOHANSEN, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.008 · Cited by 317
The potential role of aluminium in Alzheimer's disease
Campbell, A. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_2.17 · Cited by 315
Quan, F.-S., Huang, C., Compans, R. W., & Kang, S.-M. (2007) · Journal of Virology · doi:10.1128/jvi.02052-06 · Cited by 313
Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype
Demento, S. L., Cui, W., Criscione, J. M., Stern, E., Tulipan, J., Kaech, S. M., & Fahmy, T. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.041 · Cited by 304
Gutierro, I., Hernández, R. M., Igartua, M., Gascón, A. R., & Pedraz, J. L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00435-8 · Cited by 292
Maurer, P., Jennings, G. T., Willers, J., Rohner, F., Lindman, Y., Roubicek, K., Renner, W. A., Müller, P., & Bachmann, M. F. (2005) · European Journal of Immunology · doi:10.1002/eji.200526285 · Cited by 279 · cited 12×
“The baculovirus expression system is most commonly used for the generation of VLPs, and has a good safety profile since baculoviruses do not naturally infect humans.”
BackgroundInfluentialLai, S. K., Hida, K., Man, S. T., Chen, C., Machamer, C., Schroer, T. A., & Hanes, J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.02.021 · Cited by 264
Sonaje, K., Chuang, E.-Y., Lin, K.-J., Yen, T.-C., Su, F.-Y., Tseng, M. T., & Sung, H.-W. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200572t · Cited by 253
Elamanchili, P., Diwan, M., Cao, M., & Samuel, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.12.032 · Cited by 246
Tokumitsu, H., Ichikawa, H., & Fukumori, Y. (1999) · Pharmaceutical Research · doi:10.1023/a:1018995124527 · Cited by 239
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.
Fries, L. F., Gordon, D. M., Richards, R. L., Egan, J. E., Hollingdale, M. R., Gross, M., Silverman, C., & Alving, C. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.358 · Cited by 228
Akagi, T., Baba, M., & Akashi, M. (2011) · Advances in Polymer Science · doi:10.1007/12_2011_150 · Cited by 227
Harrison, R. L., & Jarvis, D. L. (2006) · Advances in Virus Research · doi:10.1016/s0065-3527(06)68005-6 · Cited by 218
Uto, T., Wang, X., Sato, K., Haraguchi, M., Akagi, T., Akashi, M., & Baba, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2979 · Cited by 210
Villiers, C. L., Freitas, H., Couderc, R., Villiers, M.-B., & Marche, P. N. (2010) · Journal of Nanoparticle Research · doi:10.1007/s11051-009-9692-0 · Cited by 206
Jarvis, D. L. (2003) · Virology · doi:10.1016/s0042-6822(03)00120-x · Cited by 199
Microbial Degradation of Poly(amino acid)s
Obst, M., & Steinbüchel, A. (2004) · Biomacromolecules · doi:10.1021/bm049949u · Cited by 191
ISCOMs and other saponin based adjuvants
Barr, I. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00013-1 · Cited by 189
Sah, H. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00148-5 · Cited by 187
Evans, T. G., Bonnez, W., Rose, R. C., Koenig, S., Demeter, L., Suzich, J. A., O'Brien, D., Campbell, M., White, W. I., Balsley, J., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/320190 · Cited by 187
Correlation between particle size, in vivo particle persistence, and lung injury
Oberdorster, G., Ferin, J., & Lehnert, B. E. (1994) · Environmental Health Perspectives · doi:10.2307/3432080 · Cited by 185
Liposomal delivery of antigen to human dendritic cells
Copland, M. J., Baird, M. A., Rades, T., McKenzie, J. L., Becker, B., Reck, F., Tyler, P. C., & Davies, N. M. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00536-4 · Cited by 184
Patel, K. G., & Swartz, J. R. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100367u · Cited by 182
Pinto, L. A., Edwards, J., Castle, P. E., Harro, C. D., Lowy, D. R., Schiller, J. T., Wallace, D., Kopp, W., Adelsberger, J. W., Baseler, M. W., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/376505 · Cited by 177
Chen, Y.-S., Hung, Y.-C., Lin, W.-H., & Huang, G. S. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/19/195101 · Cited by 176
Baculovirus as a highly efficient expression vector in insect and mammalian cells
HU, Y.-C. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00078.x · Cited by 173
Liposomal vaccine delivery systems
Henriksen‐Lacey, M., Korsholm, K. S., Andersen, P. L., Perrie, Y., & Christensen, D. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.558081 · Cited by 168
Lutsiak, M. E. C., Robinson, D. R., Coester, C., Kwon, G. S., & Samuel, J. (2002) · Pharmaceutical Research · doi:10.1023/a:1020452531828 · Cited by 163
HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection
Kemp, T. J., Hildesheim, A., Safaeian, M., Dauner, J. G., Pan, Y., Porras, C., Schiller, J. T., Lowy, D. R., Herrero, R., & Pinto, L. A. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.001 · Cited by 158
Mucoadhesive chitosan-coated liposomes: characteristics and stability
Filipović‐Grčić, J., Škalko‐Basnet, N., & JALŠIENJAK, I. (2001) · Journal of Microencapsulation · doi:10.1080/026520401750038557 · Cited by 155
Interleukin‐1β, but not interleukin‐1α, is required for T‐cell‐dependent antibody production
Nakae, S., Asano, M., Horai, R., & Iwakura, Y. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01337.x · Cited by 154
Chemical Modification of Viruses and Virus-Like Particles
Strable, E., & Finn, M. G. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-69379-6_1 · Cited by 151
Liposomes and ISCOMS as vaccine formulations
Kersten, G. F. A., & Crommelin, D. J. A. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(95)00002-9 · Cited by 149
Long-term Persistence and Spectral Blue Shifting of Quantum Dots in Vivo
Fitzpatrick, J. A. J., Andreko, S. K., Ernst, L. A., Waggoner, A. S., Ballou, B. T., & Bruchez, M. P. (2009) · Nano Letters · doi:10.1021/nl901534q · Cited by 148
Feng, L., Qi, X., Zhou, X. J., Maitani, Y., Wang, S. C., Jiang, Y., & Nagai, T. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.012 · Cited by 131
Zhou, X., Zhang, X., Yu, X., Zha, X., Fu, Q., Liu, B., Wang, X., Chen, Y., Chen, Y., Shan, Y., et al. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.007 · Cited by 130
Hollister, J. R. (1998) · Glycobiology · doi:10.1093/glycob/8.5.473 · Cited by 125
Liposomes preparation methods.
Riaz, M. (1996) · PubMed · Cited by 113
Lee, P.-W., Hsu, S., Tsai, J.-S., Chen, F., Huang, P.-J., Ke, C., Liao, Z.-X., Hsiao, C., Lin, H.-J., & Sung, H. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.100 · Cited by 112
A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins
Aumiller, J. J., Hollister, J. R., & Jarvis, D. L. (2003) · Glycobiology · doi:10.1093/glycob/cwg051 · Cited by 112
SweetBac: A New Approach for the Production of Mammalianised Glycoproteins in Insect Cells
Palmberger, D., Wilson, I. B. H., Berger, I., Grabherr, R. M., & Rendić, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034226 · Cited by 108
Nonendosomal cellular uptake of ligand‐free, positively charged gold nanoparticles
Taylor, U., Klein, S., Petersen, S., Kues, W. A., Barcikowski, S., & Rath, D. (2010) · Cytometry Part A · doi:10.1002/cyto.a.20846 · Cited by 106
Wang, T., Zou, M., Jiang, H., Ji, Z., Gao, P. H., & Cheng, G. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.10.012 · Cited by 103
Emeny, R. T., Wheeler, C. M., Jansen, K. U., Hunt, W. C., Fu, T., Smith, J. F., MacMullen, S. A., Esser, M. T., & Paliard, X. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7832-7842.2002 · Cited by 101
Virus-like particles: Designing an effective AIDS vaccine
Young, K. R., McBurney, S. P., Karkhanis, L. U., & Ross, T. M. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.024 · Cited by 100
Takamura, S., Niikura, M., Li, T.-C., Takeda, N., Kusagawa, S., Takebe, Y., Miyamura, T., & Yasutomi, Y. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302193 · Cited by 99
On the structure of immune-stimulating saponin-lipid complexes (iscoms)
Kersten, G. F. A., Spiekstra, A., Beuvery, E. C., et al. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90388-o · Cited by 96
Matsusaki, M., Hiwatari, K., Higashi, M., Kaneko, T., & Akashi, M. (2004) · Chemistry Letters · doi:10.1246/cl.2004.398 · Cited by 95
Vaccine adjuvants: A priority for vaccine research
Harandi, A. M., Medaglini, D., & Shattock, R. J. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.12.084 · Cited by 94
Alving, C. R., Richards, R. L., Moss, J., Alving, L. I., Clements, J. D., Shiba, T., Kotani, S., Wirtz, R. A., & Hockmeyer, W. T. (1986) · Vaccine · doi:10.1016/0264-410x(86)90005-8 · Cited by 91
Analysis of titanium pigments in human lung tissue
Ophus, E. M., Rode, L., Gylseth, B., Nicholson, D. G., & Saeed, K. (1979) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.3104 · Cited by 89
Kasturi, S. P., Qin, H., Thomson, K. S., El-Bereir, S., Cha, S.-C., Neelapu, S. S., Kwak, L. W., & Roy, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.006 · Cited by 88
Correlation between particle size, in vivo particle persistence, and lung injury.
Oberdörster, G., Ferin, J., & Lehnert, B. E. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.102-1567252 · Cited by 87
In vivo induction of type 1 and 2 immune responses against protein antigens
Comoy, E. E. (1997) · International Immunology · doi:10.1093/intimm/9.4.523 · Cited by 87
Mohr, E., Cunningham, A. F., Toellner, K., Bobat, S., Coughlan, R. E., Bird, R. A., MacLennan, I. C. M., & Serre, K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004879107 · Cited by 85
Pushko, P., Pearce, M. B., Ahmad, A., Tretyakova, I., Smith, G., Belser, J. A., & Tumpey, T. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.068 · Cited by 79
Detoxification of endotoxin by aluminum hydroxide adjuvant
Shi, Y., HogenEsch, H., Regnier, F. E., & Hem, S. L. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00394-7 · Cited by 75
Baca‐Estrada, M. E., Földvári, M., Snider, M., Harding, K. M., Kournikakis, B., Babiuk, L. A., & Griebel, P. J. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00019-0 · Cited by 75
Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid
Reid, G. (1992) · Vaccine · doi:10.1016/0264-410x(92)90439-q · Cited by 66
Some Observations on the Use of Alum Precipitated Diphtheria Toxoid
Harrison, W. T. (1935) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.25.3.298 · Cited by 64
Preparation, Characterization, and Biological Analysis of Liposomal Formulations of Vincristine
Waterhouse, D., Madden, T. D., Cullis, P. R., Bally, M. B., Mayer, L. D., & Webb, M. S. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)91002-1 · Cited by 63
Murray, R. D. H., & Robinson, J. A. (1991) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-7091-9141-5 · Cited by 62
Liposomes as delivery systems for nasal vaccination: strategies and outcomes
Heurtault, B., Frisch, B., & Pons, F. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.488687 · Cited by 61
Oppermann, F. B., Pickartz, S., & Steinbüchel, A. (1998) · Polymer Degradation and Stability · doi:10.1016/s0141-3910(97)00175-4 · Cited by 61
Novel nanoparticles for the delivery of recombinant hepatitis B vaccine
Bharali, D. J., Pradhan, V., Elkin, G., Wu, Q., Hutson, A. D., Mousa, S. A., & Thanavala, Y. M. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.05.006 · Cited by 57
Li, X., Deng, X., Yuan, M., Xiong, C., Huang, Z., Zhang, Y., & Jia, W. (2000) · Journal of Applied Polymer Science · doi:10.1002/1097-4628(20001003)78:1<140::aid-app180>3.0.co;2-p · Cited by 54
Characterization of the MN gp120 HIV-1 Vaccine: Antigen Binding to Alum
Weissburg, R. P., Berman, P. W., Cleland, J. L., Eastman, D. J., Farina, F., Frie, S. W., Lim, A., Mordenti, J. J., Peterson, M. R., Yim, K., et al. (1995) · Pharmaceutical Research · doi:10.1023/a:1016266916893 · Cited by 48
Preparation of Size Tunable Amphiphilic Poly(amino acid) Nanoparticles
Kim, H., Akagi, T., & Akashi, M. (2009) · Macromolecular Bioscience · doi:10.1002/mabi.200800367 · Cited by 46
Caputo, A., Castaldello, A., Brocca‐Cofano, E., Voltan, R., Bortolazzi, F., Altavilla, G., Sparnacci, K., Laus, M., Tondelli, L., Gavioli, R., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.047 · Cited by 46
Shailesh, S., Neelam, S., Sandeep, K., & Gd, G. (2009) · Cited by 44
Karkada, M., Weir, G. M., Quinton, T., Fuentes-Ortega, A., & Mansour, M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.025 · Cited by 42
Bot, A. I., Smith, K. A., & von Herrath, M. (2004) · DNA and Cell Biology · doi:10.1089/104454904323145227 · Cited by 41
Varshosaz, J., Ahmadi, F., Emami, J., Tavakoli, N., Minaiyan, M., Mahzouni, P., & Dorkoosh, F. A. (2010) · Journal of Microencapsulation · doi:10.3109/02652048.2010.529947 · Cited by 32
Enhancement of correct protein folding in vivo by a non-lytic baculovirus
Ho, Y.-H., Lo, H.-R., Lee, T.-C., Wu, C. P., & Chao, Y. (2004) · Biochemical Journal · doi:10.1042/bj20040007 · Cited by 29
SUPERCRITICAL FLUID TECHNIQUE FOR PARTICLE ENGINEERING: DRUG DELIVERY APPLICATIONS
del Valle, E. M. M., & Galán, M. Á. (2005) · Reviews in Chemical Engineering · doi:10.1515/revce.2005.21.1.33 · Cited by 27
Getting Closer to the Dirty Little Secret
Pelka, K., & Latz, E. (2011) · Immunity · doi:10.1016/j.immuni.2011.04.003 · Cited by 23
Ma, J., Bulger, P. A., Dante, S., Davis, D. V., Perilli-Palmer, B. A., & Coughlin, R. T. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.4.909 · Cited by 21
Ertürk, M., Jennings, R., PHILLPOTTS, R. J., et al. (1991) · Vaccine · doi:10.1016/0264-410x(91)90193-a · Cited by 17
Anthrax sub-unit vaccine: The structural consequences of binding rPA83 to Alhydrogel®
Soliakov, A., Kelly, I. F., Lakey, J. H., & Watkinson, A. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.09.009 · Cited by 17
Recent advances in immunological adjuvants: the development of particulate antigen delivery systems
O’Hagan, D. T. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.3.349 · Cited by 12
T.9.5. Aluminum Hydroxide Adjuvants Activate the Immune System Through the Nalp3 Inflammasome
Eisenbarth, S. C., Cassel, S., Sutterwala, F. S., & Flavell, R. A. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.03.140 · Cited by 1
Cited by
Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties
Sukhanova, A., Bozrova, S., Sokolov, P., Berestovoy, M., Karaulov, A., & Nabiev, I. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2457-x · Cited by 1,107
Zhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response
Kim, O. Y., Park, H. T., Dinh, N. T. H., Choi, S. J., Lee, J., Kim, J. H., Lee, S.-W., & Gho, Y. S. (2017) · Nature Communications · doi:10.1038/s41467-017-00729-8 · Cited by 616
Polymeric nanoparticles: Promising platform for drug delivery
El-Say, K. M., & El-Sawy, H. S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.052 · Cited by 608
Liposomes as vaccine delivery systems: a review of the recent advances
Schwendener, R. A. (2014) · Therapeutic Advances in Vaccines · doi:10.1177/2051013614541440 · Cited by 525
Metadata
- Authors
- Gregory, A. E., Titball, R., & Williamson, D.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 3
- Pages
- 13-13
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W1998989840
- Cited by
- 561
- References
- 140
- FWCI
- 20.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.